Product Details

CAT No.# CS-CM-00136
Category Metabolites
CAS 10089-10-8
Molecular Weight 443.7
Molecular Formula C20H17Cl3O5
Synonyms: (E)-6-(but-2-en-2-yl)-2,4,7-trichloro-3-hydroxy-8-methoxy-1,9-dimethyl-11H-dibenzo[b,e][1,4]dioxepin-11-one
Application Notes: Nidulin is a depsidone produced by several fungal species with potent and selective antibacterial activity. While literature relating to nidulin is limited, it is closely related to folipasatin and unguinol, both of which have been identified as inhibitors of phospholipase A2, arachidonic acid release from rat polymorphonuclear leukocytes, and nitrendipine binding to porcine heart membrane. While showing some calcium blocking attributes, these metabolites have potential as antiinflammatory agents.Nidulin and ustin; two chlorine-containing metabolic products of Aspergillus nidulans.
References: Thammarat Aree, Sanya Surerum, Nattaya Ngamrojanavanich and Prasat Kittakoop . , Acta Cryst (2009). E65, o2470-o2471   
COA / MSDS:    View COA    MSDS    Enquire
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
PEOPLE ALSO SEARCHED FOR: 1. (6R,7S)-7-(2-chloroacetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
2. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
3. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
4. Benidipine D7
5. Lauroside D
6. Triazolam 13C D3
7. Icatibant impurity 1
9. 0.1% TFA in Water ULC-MS
10. Metamizole EP Impurity C HCl
11. Silodosin Metabolite D4
12. Brivaracetam Carboxylic acid metabolite [UCB 42145]
13. Terbuthylazine D5
14. tibolone (848)
15. (Z)-Dimethylvinphos
16. Silodosin Metabolite
17. 2-Phenoxymethanesulfonanilide
18. Nimesulide EP Impurity A
19. Acetone HPLC
20. Nandrolone Decanoate EP impurity F

This page contains information about Nidulin Cas 10089-10-8 and its Metabolites.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."